menu ☰
menu ˟

Draft guidance from NICE asks for more information on multiple sclerosis treatment

21 Feb 2014
The National Institute for Health and Care Excellence (NICE) is calling on Biogen Idec to provide more information on its multiple sclerosis drug, dimethyl fumarate (also called Tecfidera). In draft guidance published for consultation, NICE has reque...

Click here to view the full article which appeared in National Institute for Health and Clinical Excellence (NICE)

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.